Literature DB >> 4045232

Immunotyping of Chlamydia trachomatis with monoclonal antibodies.

S P Wang, C C Kuo, R C Barnes, R S Stephens, J T Grayston.   

Abstract

Rapid and precise immunotyping of Chlamydia trachomatis was achieved by testing whole organisms (elementary bodies) in the microimmunofluorescence test with monoclonal antibodies. Monoclonal antibodies were produced with standard techniques by using an immunization schedule that encouraged the development of immunotype-specific antibodies. Fifteen monotypic or multitypic (subspecies) monoclonal antibodies were chosen for use in a two-step typing system that required strains of C. trachomatis to be tested against six to eight monoclonal antibodies for classification. Immunotyping with monoclonal antibodies was studied by testing 313 strains, typed with the previous method that utilized immunized mouse antisera, that represented each of the 15 established serovars. The two-step monoclonal antibody method resulted in a classification similar to the current one. Only one strain typed differently with the two methods. With the monoclonal antibody method, available lymphogranuloma venereum (LGV) serovars L1 and L3 could not be differentiated from trachoma serovars E and G, respectively, unless the strains had been identified as LGV. Monoclonal antibody typing was simpler to perform and more precise; it allowed easy differentiation between closely related serovars. Three new types were discovered among the strains previously classified as serovars D, I, and L2. These are tentatively being considered subtypes and are labeled D', I', and L2'.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4045232     DOI: 10.1093/infdis/152.4.791

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  85 in total

Review 1.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Serovar distribution of urogenital C trachomatis isolates in Germany.

Authors:  H Näher; D Petzoldt
Journal:  Genitourin Med       Date:  1991-04

3.  Immunochemical diversity of the major outer membrane protein of avian and mammalian Chlamydia psittaci.

Authors:  H Fukushi; K Hirai
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

4.  Comparison of immunotyping of Chlamydia trachomatis by indirect fluorescent-antibody staining and radioimmunoassay.

Authors:  B J van der Pol; R B Jones
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

5.  Development of secondary inclusions in cells infected by Chlamydia trachomatis.

Authors:  Robert J Suchland; Daniel D Rockey; Sara K Weeks; Damir T Alzhanov; Walter E Stamm
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  Serotyping of Chlamydia trachomatis by indirect fluorescent-antibody staining of inclusions in cell culture with monoclonal antibodies.

Authors:  S P Wang; J T Grayston
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

7.  Identification of a new group of Chlamydia psittaci strains called TWAR.

Authors:  C C Kuo; H H Chen; S P Wang; J T Grayston
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

8.  Serovars of Chlamydia trachomatis causing postabortion salpingitis.

Authors:  K Persson; S Osser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

9.  Murine cytotoxic T lymphocytes induced following Chlamydia trachomatis intraperitoneal or genital tract infection respond to cells infected with multiple serovars.

Authors:  M N Starnbach; M J Bevan; M F Lampe
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Chlamydia trachomatis serovar differentiation by direct sequence analysis of the variable segment 4 region of the major outer membrane protein gene.

Authors:  E Poole; I Lamont
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.